|
03.05.2019 08:23:00
|
Medicover: Interim Report January-March 2019
STOCKHOLM, May 3, 2019 /PRNewswire/ --
- Revenue increased by 23.3% to €199.7m (€161.9m). Organic revenue grew by 15.4%.
- Operating profit amounted to €11.3m (€9.0m), representing an operating margin of 5.7% (5.6%).
- Net profit amounted to €6.9m (€8.5m), which represents a net profit margin of 3.5% (5.3%).
- EBITDA increased by 23.9% to €27.5m (€22.2m), corresponding to an EBITDA margin of 13.8% (13.7%).
- Cash flow from operating activities increased to €24.1m (€13.7m).
- Basic/diluted earnings per share were €0.046 (€0.060).
- Members increased by 14.5% to 1,232K.
REVENUE AND EARNINGS
€ millions (€m) | Q1 2019 | Q1 2018 | Growth | FY 2018
|
Revenue | 199.7 | 161.9 | 23% | 671.6 |
Operating profit | 11.3 | 9.0 | 26% | 33.7 |
Operating profit margin, % | 5.7% | 5.6% | 5.0% | |
Net profit | 6.9 | 8.5 | -19% | 24.2 |
Net profit margin, % | 3.5% | 5.3% | 3.6% | |
Basic/diluted earnings per share, € | 0.046 | 0.060 | -23% | 0.167 |
EBITDA | 27.5 | 22.2 | 24% | 90.7 |
EBITDA margin, % | 13.8% | 13.7% | 13.5% | |
EBITDAaL | 18.5 | 14.5 | 28% | 58.5 |
EBITDAaL margin, % | 9.3% | 9.0% | 8.7% | |
EBITA | 12.5 | 9.6 | 30% | 37.0 |
EBITA margin, % | 6.3% | 5.9% | 5.5% |
For definition and reconciliation of alternative performance measures, refer to note 9.
All comparative figures have been restated for the impact of the adoption of IFRS 16, Leases compared to the published consolidated financial statements as at and for the year ended 2018. Refer to the restatement release of 17 April 2019.
Contact information
For further information, please contact:
Hanna Bjellquist
Head of Investor Relations
Phone: +46-70-303-32-72
E-mail: hanna.bjellquist@medicover.com
This is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication through the agency of the contact person set out above at 8.00 (CEST) on 3 May 2019. This interim report and other information about Medicover is available at medicover.com.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2018, Medicover had revenue around €672 million and 20,970 employees. For more information, go to www.medicover.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/medicover/r/interim-report-january-march-2019,c2802439
The following files are available for download:
https://mb.cision.com/Main/15662/2802439/1036366.pdf | Interim report January-March 2019 |
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medicover AB Registered Shs -B-mehr Nachrichten
|
29.10.24 |
Ausblick: Medicover Registered B präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
|
15.10.24 |
Erste Schätzungen: Medicover Registered B gewährt Anlegern Blick in die Bücher (finanzen.net) | |
|
24.07.24 |
Ausblick: Medicover Registered B verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
|
10.07.24 |
Erste Schätzungen: Medicover Registered B stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) |
Analysen zu Medicover AB Registered Shs -B-mehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.